Pain following injection of urethral elastomer bulking agent
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
35916898
DOI
10.1007/s00192-022-05314-2
PII: 10.1007/s00192-022-05314-2
Knihovny.cz E-zdroje
- Klíčová slova
- Bulking agent, Incontinence, Urolastic,
- MeSH
- bolest MeSH
- injekce MeSH
- lidé MeSH
- stresová inkontinence moči * farmakoterapie MeSH
- uretra * MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Zobrazit více v PubMed
Hoe V, Haller B, Yao H, O'Connell H. Urethral bulking agents for the treatment of stress urinary incontinence in women: A systematic review. Neurourol Urodynam. 2021;40(6):1349–88. DOI
Futyma K, Nowakowski Ł, Gałczyński K, Miotła P, Rechberger T. Nonabsorbable urethral bulking agent — clinical effectiveness and late complications rates in the treatment of recurrent stress urinary incontinence after 2 years of follow-up. Eur J Obstet Gynecol Reproductive Biol. 2016;207:68–72. DOI
Capobianco G, Azzena A, Saderi L, Dessole F, Dessole S, Sotgiu G. Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2018;29(9):1239–47. DOI
Casteleijn F, Kowalik C, Berends C, Blaganje M, Lasić Pecev M, Linden E, et al. Patients' satisfaction and safety of bulk injection therapy Urolastic for treatment of stress urinary incontinence: A cross-sectional study. Neurourol Urodynam. 2020;39(6):1753–63. DOI
